Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Delivra Corp (DVA.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 23,265
  • Shares Outstanding, K 47,480
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 3.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings -0.02 on 12/31/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.425 +15.29%
on 05/21/19
0.490 unch
on 05/23/19
+0.025 (+5.38%)
since 04/23/19
3-Month
0.320 +53.13%
on 02/28/19
0.610 -19.67%
on 03/19/19
+0.140 (+40.00%)
since 02/22/19
52-Week
0.230 +113.04%
on 12/27/18
0.610 -19.67%
on 03/19/19
+0.095 (+24.05%)
since 05/23/18

Most Recent Stories

More News
States Attract New Wave of Tourism With Legalized Cannabis

Last year, Canada became the second country ever to legalize cannabis entirely, joining Uruguay as the world pacesetters. Now, visitors across the world are flocking to the nation to try legal cannabis....

BIOIF : 0.4355 (+1.68%)
CPST : 0.85 (+3.66%)
EMHTF : 2.8180 (+3.60%)
DVA.VN : 0.490 (+6.52%)
BIO.CN : 0.570 (-3.39%)
EMH.VN : 3.770 (+2.45%)
TRTC : 0.7500 (+3.65%)
HRVOF : 0.6200 (-3.12%)
HVT.VN : 0.820 (-3.53%)
Harvest One Acquires Delivra to Strengthen its Medical and Wellness Division

Harvest One Cannabis Inc. (TSXV: HVT, OTCQX: HRVOF - "Harvest One") and Delivra Corp. (TSXV: DVA - "Delivra") are pleased to announce today that they have entered into a definitive arrangement agreement...

DVA.VN : 0.490 (+6.52%)
HRVOF : 0.6200 (-3.12%)
Harvest One Acquires Delivra to Strengthen its Medical and Wellness Division

TORONTO , March 4, 2019 /PRNewswire/ - Harvest One Cannabis Inc. (TSXV: HVT, OTCQX: HRVOF – " Harvest One ") and Delivra Corp. (TSXV: DVA – " Delivra ") are pleased to announce today...

DVA.VN : 0.490 (+6.52%)
DLRVF : 0.3674 (+10.50%)
HRVOF : 0.6200 (-3.12%)
HVT.VN : 0.820 (-3.53%)
IIROC Trading Resumption - DVA

VANCOUVER , March 4, 2019 /CNW/ - Trading resumes in:

DVA.VN : 0.490 (+6.52%)
IIROC Trading Resumption - DVA

Trading resumes in:

DVA.VN : 0.490 (+6.52%)
IIROC Trading Halt - DVA

VANCOUVER , March 4, 2019 /CNW/ - The following issues have been halted by IIROC:

DVA.VN : 0.490 (+6.52%)
Delivra Publishes Positive Results Utilizing its Unique Platform Technology for Topical Doxycycline

Delivra Corp. (TSXV: DVA - "Delivra" or the "Company") today announced the publication of positive data from a laboratory and clinical study demonstrating the stability, safety and efficacy to treat diabetic...

DVA.VN : 0.490 (+6.52%)
Delivra publishes positive results utilizing its novel platform technology for Varicose Veins

Delivra Corp. (TSXV: DVA - "Delivra" or the "Company") today announced the publication of positive data from a clinical study demonstrating the safety and efficacy to treat chronic venous insufficiency...

DVA.VN : 0.490 (+6.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.510
1st Resistance Point 0.500
Last Price 0.490
1st Support Level 0.470
2nd Support Level 0.450

See More

52-Week High 0.610
Last Price 0.490
Fibonacci 61.8% 0.465
Fibonacci 50% 0.420
Fibonacci 38.2% 0.375
52-Week Low 0.230

See More

Business Summary

Delivra Corp is a specialty biotechnology company. It is a developer of transdermal technologies for the delivery of pharmaceutical and natural molecules, through the skin. It manufactures and sells natural topical creams under the LivRelief, and LivSport brand. The LivRelief brand, for conditions such...

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar